局部晚期直肠癌长疗程新辅助放化疗与手术之间的最佳等待时间：一个两难困境。 - Suppr | 超能文献

Optimal wait between long-course neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: a dilemma.

作者信息

Aggarwal Gaurav, Roy Manas K, Banerjee Sudeep

出版信息

ANZ J Surg. 2014 Jan-Feb;84(1-2):4-5. doi: 10.1111/ans.12449.

DOI:10.1111/ans.12449

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Optimal wait between long-course neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: a dilemma.局部晚期直肠癌长疗程新辅助放化疗与手术之间的最佳等待时间：一个两难困境。

ANZ J Surg. 2014 Jan-Feb;84(1-2):4-5. doi: 10.1111/ans.12449.

2

[Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].[优化新辅助治疗在局部晚期直肠癌治疗中的进展]

Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jun 25;22(6):527-533. doi: 10.3760/cma.j.issn.1671-0274.2019.06.005.

3

Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit.局部晚期直肠癌的全新辅助治疗：导火索已点燃。

Br J Surg. 2020 Dec;107(13):1705-1707. doi: 10.1002/bjs.12014. Epub 2020 Oct 26.

4

The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.新辅助放化疗后病理淋巴结阴性的直肠癌患者根治性手术后辅助化疗对生存和复发的影响。

Colorectal Dis. 2017 Nov;19(11):980-986. doi: 10.1111/codi.13714.

5

Associations between clinical characteristics and tumor response to neoadjuvant chemoradiotherapy in rectal cancer.直肠癌新辅助放化疗的临床特征与肿瘤反应的相关性。

Cancer Med. 2021 Jul;10(14):4832-4843. doi: 10.1002/cam4.4051. Epub 2021 Jun 15.

6

Impact of Surgical Complications Following Resection of Locally Advanced Rectal Adenocarcinoma on Adjuvant Chemotherapy Delivery and Survival Outcomes.局部晚期直肠腺癌切除术后手术并发症对辅助化疗实施及生存结局的影响

Dis Colon Rectum. 2016 Oct;59(10):916-24. doi: 10.1097/DCR.0000000000000659.

7

Management of rectal cancer: the 2016 French guidelines.直肠癌治疗：2016 年法国指南。

Colorectal Dis. 2017 Feb;19(2):115-122. doi: 10.1111/codi.13550.

8

Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).韩国结直肠外科学会（KSCP）新辅助同期放化疗后局部中低位进展期直肠癌巩固化疗的临床试验：一项多中心、随机对照试验（KONCLUDE）。

BMC Cancer. 2018 May 8;18(1):538. doi: 10.1186/s12885-018-4466-7.

9

Treatment approach in locally advanced rectal cancer during coronavirus (COVID-19) pandemic: long course or short course?新型冠状病毒肺炎（COVID-19）大流行期间局部晚期直肠癌的治疗方法：长疗程还是短疗程？

Colorectal Dis. 2020 Jun;22(6):642-643. doi: 10.1111/codi.15058. Epub 2020 Apr 25.

10

[Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].新辅助放化疗及全直肠系膜切除术后MRI评估局部晚期直肠癌无进展生存期

Zhonghua Zhong Liu Za Zhi. 2018 Feb 23;40(2):121-126. doi: 10.3760/cma.j.issn.0253-3766.2018.02.008.